Published on GHDx (https://ghdx.healthdata.org)

Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa

General Info

Geography 
Angola (AGO)
Benin (BEN)
Botswana (BWA)
Burkina Faso (BFA)
Burundi (BDI)
Cabo Verde (CPV)
Cameroon (CMR)
Central African Republic (CAF)
Chad (TCD)
Comoros (COM)
Congo (COG)
Côte d'Ivoire (CIV)
Democratic Republic of the Congo (COD)
Djibouti (DJI)
Equatorial Guinea (GNQ)
Eritrea (ERI)
Ethiopia (ETH)
Gabon (GAB)
Gambia (GMB)
Ghana (GHA)
Guinea (GIN)
Guinea-Bissau (GNB)
Kenya (KEN)
Lesotho (LSO)
Liberia (LBR)
Madagascar (MDG)
Malawi (MWI)
Mali (MLI)
Mauritania (MRT)
Mauritius (MUS)
Mozambique (MOZ)
Namibia (NAM)
Niger (NER)
Nigeria (NGA)
Rwanda (RWA)
Sao Tome and Principe (STP)
Senegal (SEN)
Seychelles (SYC)
Sierra Leone (SLE)
Somalia (SOM)
South Africa (ZAF)
Sudan (SDN)
Eswatini (SWZ)
Togo (TGO)
Uganda (UGA)
United Republic of Tanzania (TZA)
Zambia (ZMB)
Zimbabwe (ZWE)
View all
Time period covered 
January, 2010 - December, 2012
Data type
Scientific literature
Keywords 
Cancers, Cervix uteri cancer, HPV, HPV vaccines, Incidence, Preventive interventions

Citation

Authors 
Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I
Journal 
Vaccine
Pages 
F60-72
Publication year 
2013
Suggested citation 
Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Vaccine. 2013; 31 Suppl 5: F60-72.
Source URL:https://ghdx.healthdata.org/record/model-based-impact-and-cost-effectiveness-cervical-cancer-prevention-sub-saharan-africa